ticlopidine /ti·clo·pi·dine/ (ti-klo´pĭ-dēn) a platelet inhibitor used as the hydrochloride salt in the prophylaxis of stroke syndrome.
ticlopidine
ticlopidine [ti-klo´pĭ-dēn]
ticlopidine (tīklō´p
dēn),
ticlopidine
ticlopidine
[tiklo′pidēn]
a platelet inhibitor used as the hydrochloride salt in the prevention of stroke syndrome.
ticlopidine [ti-klo´pĭ-dēn]
a platelet inhibitor used as the hydrochloride salt in the prevention of stroke syndrome.
ticlopidine (tīklō´p
dēn),n brand name: Ticlid;
drug class: platelet aggregation inhibitor;
action: inhibits first and second phases of adenosine diphosphate (ADP)-induced effects in platelet aggregation;
use: effective in reducing the risk of stroke in high-risk patients.
drug class: platelet aggregation inhibitor;
action: inhibits first and second phases of adenosine diphosphate (ADP)-induced effects in platelet aggregation;
use: effective in reducing the risk of stroke in high-risk patients.
ticlopidine
an antiplatelet drug used in thrombotic diseases such as heartworm disease in dogs.
ticlopidine
Therapeutics A platelet aggregation inhibitor that alters the platelet membrane, interfering with membrane-fibrinogen interaction by blocking platelet gpIIb/IIIa receptor Indications ↓ Stroke in high risk Pts, minimize stroke
progression, cerebral ischemia, progression of diabetic retinopathy Side effects BM suppression with severe reversible neutropenia, diarrhea, rash, gastritis or gastric ulcers–nausea, dyspepsia, hemorrhage, thrombocytopenia, ↑
cholesterol. See TIA.
Want to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit the webmaster's page for free fun content.
| ?Page tools | ||
|---|---|---|
|